ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Amifostine and High-Dose Combination Chemotherapy in Treating Patients With Acute Myeloid Leukemia or Chronic Myelogenous Leukemia

This study is ongoing, but not recruiting participants.
Study NCT00003407.   Last updated on October 18, 2008.   Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:
1 Conditions listed in this trial
Cancer-Related Problem/Condition
Leukemia
Myelodysplastic Syndromes
2 Additional conditions recognized in this trial
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Leukemia, Myeloid
Leukemia, Myeloid, Acute
Preleukemia
Syndrome
3 More general conditions related to this trial
Bone Marrow Diseases
Disease
Hematologic Diseases
Myeloproliferative Disorders
Neoplasms
Neoplasms by Histologic Type
Pathologic Processes
Precancerous Conditions
4 Interventions listed in this trial
amifostine trihydrate
cytarabine
mitoxantrone hydrochloride
5 Additional drug interventions recognized in this trial
Amifostine
Mitoxantrone
6 More general drug interventions related to this trial
Analgesics
Anti-Infective Agents
Antimetabolites
Antimetabolites, Antineoplastic
Antineoplastic Agents
Antiviral Agents
Central Nervous System Agents
Immunologic Factors
Immunosuppressive Agents
Molecular Mechanisms of Pharmacological Action
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Protective Agents
Radiation-Protective Agents
Sensory System Agents
Therapeutic Uses
7 Sponsors listed in this trial
Rush University Medical Center
National Cancer Institute (NCI)




Links to all studies - primarily for crawlers